- Home
- RGEN vs CAVA Comparison
RGEN vs CAVA Comparison
Compare RGEN & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- CAVA
- Stock Information
- Founded
- RGEN 1981
- CAVA 2006
- Country
- RGEN United States
- CAVA United States
- Employees
- RGEN N/A
- CAVA N/A
- Industry
- RGEN Medical/Dental Instruments
- CAVA Restaurants
- Sector
- RGEN Health Care
- CAVA Consumer Discretionary
- Exchange
- RGEN Nasdaq
- CAVA Nasdaq
- Market Cap
- RGEN 8.2B
- CAVA 13.9B
- IPO Year
- RGEN N/A
- CAVA 2023
- Fundamental
- Price
- RGEN $142.03
- CAVA $124.35
- Analyst Decision
- RGEN Buy
- CAVA Buy
- Analyst Count
- RGEN 10
- CAVA 13
- Target Price
- RGEN $188.38
- CAVA $109.83
- AVG Volume (30 Days)
- RGEN 778.8K
- CAVA 4.8M
- Earning Date
- RGEN 10-29-2024
- CAVA 11-05-2024
- Dividend Yield
- RGEN N/A
- CAVA N/A
- EPS Growth
- RGEN N/A
- CAVA N/A
- EPS
- RGEN N/A
- CAVA 0.38
- Revenue
- RGEN $602,354,000.00
- CAVA $845,224,000.00
- Revenue This Year
- RGEN $0.08
- CAVA $30.85
- Revenue Next Year
- RGEN $12.97
- CAVA $20.92
- P/E Ratio
- RGEN N/A
- CAVA $331.02
- Revenue Growth
- RGEN N/A
- CAVA 31.01
- 52 Week Low
- RGEN $110.45
- CAVA $29.05
- 52 Week High
- RGEN $211.13
- CAVA $128.18
- Technical
- Relative Strength Index (RSI)
- RGEN 45.65
- CAVA 67.48
- Support Level
- RGEN $135.88
- CAVA $120.25
- Resistance Level
- RGEN $150.72
- CAVA $127.00
- Average True Range (ATR)
- RGEN 5.47
- CAVA 4.47
- MACD
- RGEN -0.88
- CAVA -0.25
- Stochastic Oscillator
- RGEN 36.09
- CAVA 84.13
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates the majority of its revenue from the CAVA segment.